Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-040624
Filing Date
2014-06-11
Accepted
2014-06-11 17:31:01
Documents
2
Period of Report
2014-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10170
2 EX-24 DOCUMENT attachment1.htm EX-24 3530
  Complete submission text file 0001209191-14-040624.txt   15100
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address
GALAKATOS NICHOLAS (Reporting) CIK: 0001252522 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35935 | Film No.: 14905466

Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Issuer) CIK: 0001269021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations